Testing a New Weight-Loss Injection in Healthy Adults
Part of Hormones & metabolism clinical trials.
This study tests a new injectable medication (SYH2082) that works like GLP-1 and GIP drugs to see how safe it is and how your body handles it. You must be healthy with no diabetes, thyroid cancer risk, or recent major surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–65 and healthy with no significant medical conditions
- Body weight at least 50 kg (men) or 45 kg (women), with BMI between 22–40 and stable weight (no more than 5% change in 3 months)
- No allergy to GLP-1 or GIP medications, or multiple drug/food allergies
- No diabetes, history of low blood sugar, or family history of medullary thyroid cancer or multiple endocrine neoplasia
- No recent major surgery (within 3 months), severe depression, suicide attempts, or use of GLP-1/GIP drugs in the past 3 months
- Willing to use contraception and abstain from alcohol, smoking, and excess caffeine during the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new injection called SYH2092 in healthy adults, not for treating a disease. Participation helps researchers understand how the drug works in the body and if it is safe. If you qualify, you may be compensated for your time.
This trial tests a new injection (BGM1812) for weight loss in people who are overweight or obese. The injection is given under the skin, and the study will see how it works in your body and how safe it is.
This study tests an investigational weight-loss injection, IN-B00009, for adults with obesity or overweight who don't have diabetes. It aims to see if the drug is safe and effective for helping you lose weight, along with diet and exercise.
This study tests a new injectable medication for weight management in people with overweight or obesity. It investigates how the drug interacts with other medications and checks its safety. Participation requires a 6-month commitment with regular study visits.
This study tests a new injected medicine that may help people with type 2 diabetes and overweight or obesity lose weight. The trial will see how well it works and if it is safe compared to a placebo.
This study tests a new medicine to help adults with obesity or overweight lose weight. It's for people who have had trouble losing weight in the past and don't have diabetes.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.